Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 5

See more details

Blogged by 1
25 readers on Mendeley
  • Article usage
  • Citations to this article (61)

Advertisement

Research Article Free access | 10.1172/JCI106431

Reduced brain glucose with normal plasma glucose in salicylate poisoning

Jean Holowach Thurston, Philip G. Pollock, Sheila K. Warren, and Elizabeth M. Jones

1Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and the Division of Neurology, St. Louis Children's Hospital, St. Louis, Missouri 63110

Find articles by Thurston, J. in: PubMed | Google Scholar

1Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and the Division of Neurology, St. Louis Children's Hospital, St. Louis, Missouri 63110

Find articles by Pollock, P. in: PubMed | Google Scholar

1Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and the Division of Neurology, St. Louis Children's Hospital, St. Louis, Missouri 63110

Find articles by Warren, S. in: PubMed | Google Scholar

1Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and the Division of Neurology, St. Louis Children's Hospital, St. Louis, Missouri 63110

Find articles by Jones, E. in: PubMed | Google Scholar

Published November 1, 1970 - More info

Published in Volume 49, Issue 11 on November 1, 1970
J Clin Invest. 1970;49(11):2139–2145. https://doi.org/10.1172/JCI106431.
© 1970 The American Society for Clinical Investigation
Published November 1, 1970 - Version history
View PDF
Abstract

After the intraperitoneal injection into young mice of 700-800 mg/kg of salicylate, brain glucose fell to one-third or less of control values despite normal plasma glucose levels; brain lactate was nearly doubled and there were small decreases in phosphocreatine (18%) and in glycogen (17%). ATP, pyruvate, α-ketoglutarate, and glutamate were unchanged. In liver, glycogen was reduced 79% and lactate was five times higher than in control animals; glucose, glucose-6-phosphate, and ATP were unchanged.

Since salicylate uncouples oxidative phosphorylation, it is postulated that high energy phosphate in the brain is maintained near normal levels by a compensatory increase in cerebral glycolysis. Apparently the brain glucose level falls because the rate of utilization exceeds the rate at which glucose can be supplied from the blood. Concurrent administration of glucose with salicylate elevated brain glucose concentration and was associated with striking improvement in the condition and the increased survival of the animals. These findings stress the fact that in salicylate poisoning the supply of glucose to the brain may be inadequate even when blood glucose levels are normal.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2139
page 2139
icon of scanned page 2140
page 2140
icon of scanned page 2141
page 2141
icon of scanned page 2142
page 2142
icon of scanned page 2143
page 2143
icon of scanned page 2144
page 2144
icon of scanned page 2145
page 2145
Version history
  • Version 1 (November 1, 1970): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 5
  • Article usage
  • Citations to this article (61)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
25 readers on Mendeley
See more details